+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Prodrug"

From
From
Bioprocessing Analytics - Global Strategic Business Report - Product Thumbnail Image

Bioprocessing Analytics - Global Strategic Business Report

  • Report
  • October 2025
  • 371 Pages
  • Global
From
From
Monoclonal Antibody Therapeutics Market Report 2025 - Product Thumbnail Image

Monoclonal Antibody Therapeutics Market Report 2025

  • Report
  • October 2025
  • 250 Pages
  • Global
From
Tangential Flow Filtration Market Report 2025 - Product Thumbnail Image

Tangential Flow Filtration Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
From
From
From
From
Monoclonal Antibody Therapeutics (mABs) Market - Product Thumbnail Image

Monoclonal Antibody Therapeutics (mABs) Market

  • Report
  • September 2025
  • 150 Pages
  • Global
From
From
From
Loading Indicator

Prodrugs are a type of biotechnology that involves the modification of a drug molecule to improve its pharmacokinetic properties. This is done by making the drug more soluble, increasing its absorption, or making it more stable in the body. Prodrugs are designed to be more effective and safer than the original drug, and can be used to treat a variety of diseases. Prodrugs are used in a variety of therapeutic areas, including cancer, cardiovascular disease, and infectious diseases. They are also used to improve the delivery of drugs to specific tissues or organs, and to reduce the side effects of drugs. The prodrug market is growing rapidly, driven by the increasing demand for more effective and safer drugs. The market is expected to continue to grow in the coming years, as more companies develop and launch new prodrugs. Some companies in the prodrug market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more